Prognostic and predictive biomarkers for response to neoadjuvant chemoradiation in esophageal adenocarcinoma

被引：0
作者：
Hirsch Matani
Divya Sahu
Michael Paskewicz
Anastasia Gorbunova
Ashten N. Omstead
Rodney Wegner
Gene G. Finley
Blair A. Jobe
Ronan J. Kelly
Ali H. Zaidi
Ajay Goel
机构：
[1] Allegheny Health Network Cancer Institute,Division of Radiation Oncology
[2] Beckman Research Institute of City of Hope,Department of Molecular Diagnostics and Experimental Therapeutics
[3] Allegheny Health Network,Esophageal and Lung Research
[4] Charles A. Sammons Cancer Center,Department of Hematology and Oncology
[5] Baylor University Medical Center,undefined
来源：
Biomarker Research | / 10卷
关键词：
Esophageal adenocarcinoma; Risk stratification; CROSS regimen; EPHA5; BCL6; ERBB2; Predict response; Prognostic classifier;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Stage III esophageal adenocarcinoma: definitive chemoradiation vs. chemoradiation plus surgery
    Schlottmann, Francisco
    Strassle, Paula D.
    Gaber, Charles
    Patti, Marco G.
    UPDATES IN SURGERY, 2018, 70 (04) : 423 - 426
  • [22] Stage III esophageal adenocarcinoma: definitive chemoradiation vs. chemoradiation plus surgery
    Francisco Schlottmann
    Paula D. Strassle
    Charles Gaber
    Marco G. Patti
    Updates in Surgery, 2018, 70 : 423 - 426
  • [23] Podocalyxin-like protein as a predictive biomarker for benefit of neoadjuvant chemotherapy in resectable gastric and esophageal adenocarcinoma
    Borg, David
    Larsson, Anna H.
    Hedner, Charlotta
    Nodin, Bjorn
    Johnsson, Anders
    Jirstrom, Karin
    JOURNAL OF TRANSLATIONAL MEDICINE, 2018, 16
  • [24] Podocalyxin-like protein as a predictive biomarker for benefit of neoadjuvant chemotherapy in resectable gastric and esophageal adenocarcinoma
    David Borg
    Anna H. Larsson
    Charlotta Hedner
    Björn Nodin
    Anders Johnsson
    Karin Jirström
    Journal of Translational Medicine, 16
  • [25] Chemoradiation induces epithelial-to-mesenchymal transition in esophageal adenocarcinoma
    Steins, Anne
    Ebbing, Eva A.
    Creemers, Aafke
    van der Zalm, Amber P.
    Jibodh, Rajni A.
    Waasdorp, Cynthia
    Meijer, Sybren L.
    van Delden, Otto M.
    Krishnadath, Kausilia K.
    Hulshof, Maarten C. C. M.
    Bennink, Roelof J.
    Punt, Cornelis J. A.
    Medema, Jan Paul
    Bijlsma, Maarten F.
    van Laarhoven, Hanneke W. M.
    INTERNATIONAL JOURNAL OF CANCER, 2019, 145 (10) : 2792 - 2803
  • [26] Indications for neoadjuvant radiation in esophageal adenocarcinoma: Times are changing
    Worrell, Stephanie G.
    JTCVS TECHNIQUES, 2024, 25 : 201 - 203
  • [27] The Roles of Neoadjuvant Radiotherapy and Lymphadenectomy in the Treatment of Esophageal Adenocarcinoma
    Naveenraj Solomon
    Ying Zhuge
    Michael Cheung
    Dido Franceschi
    Leonidas G. Koniaris
    Annals of Surgical Oncology, 2010, 17 : 791 - 803
  • [28] Role of surgery following neoadjuvant chemoradiation in patients with lymph node positive locally advanced esophageal adenocarcinoma: a national cancer database analysis
    Mamdani, Hirva
    Birdas, Thomas
    Jalal, Shadia, I
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 12 (05) : 1944 - 1950
  • [29] Esophageal adenocarcinoma with any component of signet ring cells portends poor prognosis and response to neoadjuvant therapy
    Corsini, Erin M.
    Foo, Wai Chin
    Mitchell, Kyle G.
    Zhou, Nicolas
    Maru, Dipen M.
    Ajani, Jaffer A.
    Hofstetter, Wayne L.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2021, 162 (05) : 1404 - +
  • [30] Value of Lymphadenectomy in Patients Receiving Neoadjuvant Therapy for Esophageal Adenocarcinoma
    Raja, Siva
    Rice, Thomas W.
    Murthy, Sudish C.
    Ahmad, Usman
    Semple, Marie E.
    Blackstone, Eugene H.
    Ishwaran, Hemant
    ANNALS OF SURGERY, 2021, 274 (04) : E320 - E327
12345